Reporting guideline provided for? (i.e. exactly what the authors state in the paper)
Reporting of clinical studies evaluating platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs).
Full bibliographic reference
Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells. J Bone Joint Surg Am. 2017;99(10):809-819.
Language
English
PubMed ID
Reporting guideline website URL
Reporting guideline acronym
MIBO
Study design
Clinical trials, Experimental studies, Observational studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews
Clinical area
Rheumatology, Sport and exercise medicine, Surgery
Applies to the whole report or to individual sections of the report?
Ethical issues (consent etc.), Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.)
Additional information
Murray IR, Murray AD, Geeslin AG, Goudie EB, White TO, Petrigliano FA, LaPrade RF. Infographic: we need minimum reporting standards for biologics. Br J Sports Med. 2017. PMID: 28831016
Record last updated on
November 25, 2021
Training
The UK EQUATOR Centre runs training on how to write using reporting guidelines.